Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: Development of anti-survival factor therapy for hormone-refractory prostate cancer
M. Koutsilieris et al., Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: Development of anti-survival factor therapy for hormone-refractory prostate cancer, MOL MED, 6(4), 2000, pp. 251-267
Citations number
147
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics